Dose Escalation With Enbrel(R) Is Significantly Lower Than Other Commonly Used Anti-TNF Agents In...
                   
medicalnewstoday.com     Apr 25, 2008            

New pan-European data presented at the British Society of Rheumatology's annual meeting in Liverpool demonstrate that patients treated with Enbrel® (etanercept) required significantly lower dose escalation than patients treated with infliximab and adalimumab in the first 12 months of therapy. [read full story]                    


View all news articles about*:
Ambulatory Arthritis Biopharmaceuticals Bones Care Child Childhood Diseases Disorders Health Joints Juvenile Medical Medicines Patients Pharmaceuticals Remedies Research Rheumatism Rheumatoid Rheumatology
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

                   

NIAMS Names Dr. Robert Carter as Deputy Director

nih.gov     Aug 12, 2008          

Robert H. Carter, M.D., former director of the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB), has been selected as deputy director of the National Institute of Arthritis and...                    

comments

Rapid NKT cell responses are self-terminating during the course of microbial infection.

biowizard.com     Aug 11, 2008          

Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. NKT cells play a protective role in immune responses against infectious...                    

comments

The endoplasmic reticulum stress response in immunity and autoimmunity.

biowizard.com     Aug 9, 2008          

1] Department of Infectious Diseases and Immunology, Harvard School of Public Health, 651 Huntington Avenue, Boston, Massachusetts 02115, USA. [2] Division of Rheumatology, Allergy and Immunology, Department of Medicine,...                    

comments

                   

Wyeth Reports Earnings Results for the 2008 Second Quarter and First Half and Raises Earnings...

yahoo.com     Jul 23, 2008   802 related          

Wednesday July 23, 7:00 am ET - 2008 Second Quarter Worldwide Net Revenue Increased 5% to $5.9 Billion and Reported Diluted Earnings per Share Decreased 5% to $0.83. 2008 First Half Worldwide Net Revenue Increased 6% to $11.7...                    

comments